Global Xerostomia Treatments Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 4193

Dry mouth (xerostomia) refers to a condition in which the salivary glands in your mouth don't make enough saliva to keep your mouth wet.
In 2018, the global Xerostomia Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Xerostomia Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Xerostomia Treatments development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Church and Dwight
Hikma Pharmaceuticals
Pendopharm
Parnell Pharmaceuticals
Orahealth
...

Market segment by Type, the product can be split into
Salivary Stimulants
Salivary Substitutes
Dentifrices

Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Xerostomia Treatments status, future forecast, growth opportunity, key market and key players.
To present the Xerostomia Treatments development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Xerostomia Treatments are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Xerostomia Treatments Market Size Growth Rate by Type (2014-2025)
1.4.2 Salivary Stimulants
1.4.3 Salivary Substitutes
1.4.4 Dentifrices
1.5 Market by Application
1.5.1 Global Xerostomia Treatments Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Xerostomia Treatments Market Size
2.2 Xerostomia Treatments Growth Trends by Regions
2.2.1 Xerostomia Treatments Market Size by Regions (2014-2025)
2.2.2 Xerostomia Treatments Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Xerostomia Treatments Market Size by Manufacturers
3.1.1 Global Xerostomia Treatments Revenue by Manufacturers (2014-2019)
3.1.2 Global Xerostomia Treatments Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Xerostomia Treatments Market Concentration Ratio (CR5 and HHI)
3.2 Xerostomia Treatments Key Players Head office and Area Served
3.3 Key Players Xerostomia Treatments Product/Solution/Service
3.4 Date of Enter into Xerostomia Treatments Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Xerostomia Treatments Market Size by Type (2014-2019)
4.2 Global Xerostomia Treatments Market Size by Application (2014-2019)

5 United States
5.1 United States Xerostomia Treatments Market Size (2014-2019)
5.2 Xerostomia Treatments Key Players in United States
5.3 United States Xerostomia Treatments Market Size by Type
5.4 United States Xerostomia Treatments Market Size by Application

6 Europe
6.1 Europe Xerostomia Treatments Market Size (2014-2019)
6.2 Xerostomia Treatments Key Players in Europe
6.3 Europe Xerostomia Treatments Market Size by Type
6.4 Europe Xerostomia Treatments Market Size by Application

7 China
7.1 China Xerostomia Treatments Market Size (2014-2019)
7.2 Xerostomia Treatments Key Players in China
7.3 China Xerostomia Treatments Market Size by Type
7.4 China Xerostomia Treatments Market Size by Application

8 Japan
8.1 Japan Xerostomia Treatments Market Size (2014-2019)
8.2 Xerostomia Treatments Key Players in Japan
8.3 Japan Xerostomia Treatments Market Size by Type
8.4 Japan Xerostomia Treatments Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Xerostomia Treatments Market Size (2014-2019)
9.2 Xerostomia Treatments Key Players in Southeast Asia
9.3 Southeast Asia Xerostomia Treatments Market Size by Type
9.4 Southeast Asia Xerostomia Treatments Market Size by Application

10 India
10.1 India Xerostomia Treatments Market Size (2014-2019)
10.2 Xerostomia Treatments Key Players in India
10.3 India Xerostomia Treatments Market Size by Type
10.4 India Xerostomia Treatments Market Size by Application

11 Central & South America
11.1 Central & South America Xerostomia Treatments Market Size (2014-2019)
11.2 Xerostomia Treatments Key Players in Central & South America
11.3 Central & South America Xerostomia Treatments Market Size by Type
11.4 Central & South America Xerostomia Treatments Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Xerostomia Treatments Introduction
12.1.4 GlaxoSmithKline Revenue in Xerostomia Treatments Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Church and Dwight
12.2.1 Church and Dwight Company Details
12.2.2 Company Description and Business Overview
12.2.3 Xerostomia Treatments Introduction
12.2.4 Church and Dwight Revenue in Xerostomia Treatments Business (2014-2019)
12.2.5 Church and Dwight Recent Development
12.3 Hikma Pharmaceuticals
12.3.1 Hikma Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Xerostomia Treatments Introduction
12.3.4 Hikma Pharmaceuticals Revenue in Xerostomia Treatments Business (2014-2019)
12.3.5 Hikma Pharmaceuticals Recent Development
12.4 Pendopharm
12.4.1 Pendopharm Company Details
12.4.2 Company Description and Business Overview
12.4.3 Xerostomia Treatments Introduction
12.4.4 Pendopharm Revenue in Xerostomia Treatments Business (2014-2019)
12.4.5 Pendopharm Recent Development
12.5 Parnell Pharmaceuticals
12.5.1 Parnell Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Xerostomia Treatments Introduction
12.5.4 Parnell Pharmaceuticals Revenue in Xerostomia Treatments Business (2014-2019)
12.5.5 Parnell Pharmaceuticals Recent Development
12.6 Orahealth
12.6.1 Orahealth Company Details
12.6.2 Company Description and Business Overview
12.6.3 Xerostomia Treatments Introduction
12.6.4 Orahealth Revenue in Xerostomia Treatments Business (2014-2019)
12.6.5 Orahealth Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details